| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.18B | 63.36B | 61.64B | 58.05B | 50.58B | 29.90B |
| Gross Profit | 17.07B | 14.47B | 16.56B | 15.52B | 11.16B | 2.13B |
| EBITDA | 9.66B | 8.03B | 7.92B | 8.78B | 5.05B | 3.67B |
| Net Income | 4.48B | 5.00B | 3.46B | 4.61B | 1.32B | 280.00M |
Balance Sheet | ||||||
| Total Assets | 84.43B | 81.19B | 75.37B | 73.64B | 72.28B | 72.47B |
| Cash, Cash Equivalents and Short-Term Investments | 5.05B | 4.31B | 3.07B | 3.87B | 6.53B | 11.32B |
| Total Debt | 15.00B | 21.08B | 22.77B | 27.28B | 30.61B | 34.68B |
| Total Liabilities | 64.06B | 60.43B | 60.08B | 62.54B | 65.71B | 68.57B |
| Stockholders Equity | 20.38B | 20.75B | 15.29B | 11.11B | 6.58B | 3.89B |
Cash Flow | ||||||
| Free Cash Flow | 3.92B | 3.84B | 2.88B | 1.14B | -2.00M | 16.00M |
| Operating Cash Flow | 8.40B | 8.34B | 8.03B | 6.46B | 6.36B | 3.26B |
| Investing Cash Flow | -4.22B | -4.19B | -3.74B | -3.15B | -6.92B | -897.00M |
| Financing Cash Flow | -2.88B | -3.08B | -4.26B | -3.39B | -4.54B | -3.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $12.91B | 10.91 | 135.39% | 3.50% | 6.81% | 58.22% | |
71 Outperform | $42.86B | 8.99 | 27.63% | 0.96% | 4.33% | -1.58% | |
71 Outperform | $28.88B | 10.91 | 24.13% | ― | 4.24% | 20.29% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | $18.61B | 50.61 | 5.33% | 1.73% | 0.65% | ― | |
50 Neutral | $4.23B | 69.18 | 2.47% | ― | 31.50% | -49.15% | |
46 Neutral | $7.14B | 25.57 | -2.76% | ― | 1.27% | 118.64% |